MedTrace Logo

Investigating the Effect of Standardized Olive Extract on Bone Turnover Markers in Postmenopausal Women

NCT00789425 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2017-07-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether the intake of a daily dosage of standardized olive extract provides any protection against bone loss.

Conditions

Interventions

DIETARY_SUPPLEMENT

Standardized Extract of Olive Polyphenols

Dietary supplement containing 250 mg of a standardized extract of olive polyphenols per day in 1 capsule. A supplement with 1000 mg calcium per day will be supplied together with the active treatment.

DIETARY_SUPPLEMENT

Placebo

Placebo (starch). A supplement with 1000 mg calcium per day will be supplied together with the active treatment.

Sponsors & Collaborators

  • BioActor

    lead INDUSTRY

Principal Investigators

  • Rafal Filip, MD PhD · Institute of Agricultural Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00789425 on ClinicalTrials.gov